Top

Published in:

01-04-2012 | Review

Dual- versus single-coil implantable defibrillator leads: review of the literature

Authors: Jörg Neuzner, Jörg Carlsson

Published in: Clinical Research in Cardiology | Issue 4/2012

Abstract

The preferred use of dual-coil implantable defibrillator lead systems in current implantable defibrillator therapy is likely based on data showing statistically lower defibrillation thresholds with dual-coil defibrillator lead systems. The following review will summarize the clinical data for dual- versus single-coil defibrillator leads in the left and right pectoral implant locations, and will then discuss the clinical implications of single- versus dual-coil usage for atrial defibrillation, venous complications, and the risks associated with lead extraction. It will be noted that there are no comparative clinical studies on the use and outcomes of single- versus dual-coil lead systems in implantable defibrillator therapy over a long-term follow-up. The limited long-term reliability of defibrillator leads is a major concern in implantable defibrillator and cardiac resynchronization therapy. A simpler single-coil defibrillator lead system may improve the long-term performance of implanted leads. Furthermore, the superior vena cava coil is suspected to increase interventional risk in transvenous lead extraction. Therefore, the need for objective data on extractions and complications will be emphasized.

Gradaus R, Breithardt G, Böcker D (2002) ICD leads: design and chronic dysfunctions. Pacing Clin Electrophysiol 26:649–657CrossRef

Haqqani HM, Mond HG (2009) The implantable cardioverter–defibrillator lead: principles, progress, and promises. Pacing Clin Electrophysiol 32:1336–1353PubMedCrossRef

Maisel WH (2007) Transvenous implantable cardioverter–defibrillator leads. The weakest link. Circulation 115:2461–2463PubMedCrossRef

Maisel WH, Kramer DB (2008) Implantable cardioverter–defibrillator lead performance. Circulation 117(2721):2723

Eckstein J, Koller MT, Zabel M, Kalusche D, Schaer BA, Osswald S, Sticherling C (2008) Necessity for surgical revision of defibrillator leads implanted long-term. Causes and management. Circulation 117:2727–2733PubMedCrossRef

Hauck M, Bauer A, Voss F, Weretka S, Katus HA, Becker R (2009) “Home monitoring” for early detection of implantable cardioverter–defibrillator failure: a single-center prospective observational study. Clin Res Cardiol 98:19–24PubMedCrossRef

Kleemann T, Becker T, Doenges K, Vater M, Senges J, Schneider S, Saggau W, Weisse U, Seidl K (2007) Annual rate of transvenous defibrillation lead defects in implantable cardioverter–defibrillators over a period of >10 years. Circulation 115:2474–2480PubMedCrossRef

Boriani G, Biffi M, Marziali A, Diemberger I, Martignani C (2009) A changing scenario in the clinical use of implantable defibrillators: the need for long-term data on lead performance. Europace 11:1–3PubMedCrossRef

Goette A, Cantu F, van Erven L, Geelen P, Halimi F, Merino JL, Morgan JM et al (2009) Performance and survival of transvenous defibrillation leads: need for a European data registry. Europace 11:31–34PubMedCrossRef

10.

Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA, Freedman RA, Gettes LS et al (2008) ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities. J Am Coll Cardiol 21:e1–e62CrossRef

11.

Hauser RG, Hayes DL (2009) Increasing hazard of Sprint Fidelis implantable cardioverter–defibrillator lead failure. Heart Rhythm 6:605–610PubMedCrossRef

12.

Ellis CR, Rottman JN (2009) Increased rate of subacute lead complications with small-caliber implantable cardioverter–defibrillator leads. Heart Rhythm 6:619–624PubMedCrossRef

13.

2010 Product performance reports. Boston Scientific, Inc.; Medtronic, Inc.; St. Jude Medical, Inc

14.

Gadler F (2009) Swedish pacemaker registry 2009. Available at http://www.pacemakerregistret.se/icdpmr/annualReport/2009/annualReport_2009_1.pdf

15.

Bardy GH, Johnson G, Poole JE, Dolack L, Kudenchuk PJ, Kelso D, Mitchel R, Mehra R, Hofer B (1993) A simplified, single-lead unipolar transvenous cardioversion–defibrillation system. Circulation 88:543–547PubMed

16.

Bardy GH, Yee R, Jung W (1996) Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators. J Am Coll Cardiol 28:400–410PubMedCrossRef

17.

Knuefermann P, Wolpert C, Spehl S, Korte T, Manz M, Lüderitz B, Jung W (2000) Implantable cardioverter/defibrillator: long-term stability of the defibrillation threshold with a unipolar electrode configuration (active can). Z Kardiol 89:774–780PubMedCrossRef

18.

Poole JE, Bardy GH, Kudenchuk PJ, Dolack GL, Raitt MH, Mehra R, Johnson G (1995) Prospective randomized comparison of biphasic waveform tilt using a unipolar defibrillation system. Pacing Clin Electrophysiol 18:1369–1373PubMedCrossRef

19.

Gold MR, Foster AH, Shorofsky SR (1997) Lead system optimization for transvenous defibrillation. Am J Cardiol 80:1163–1167PubMedCrossRef

20.

Gold MR, Olsovsky MR, Pelini MA, Peters RW, Shorofsky SR (1998) Comparison of single- and dual-coil active pectoral defibrillation lead systems. J Am Coll Cardiol 31:1391–1394PubMedCrossRef

21.

Gold MR, Olsovsky MR, DeGroot PJ, Cuello C, Shorofsky SR (2000) Optimization of transvenous coil position for active can defibrillation thresholds. J Cardiovasc Electrophysiol 11:25–29PubMedCrossRef

22.

Lubinski A, Lewicka-Nowak E, Zienciuk A, Krolak T, Kempa M, Pazdyga A, Raczak C, Swiatecka G (2005) Comparison of defibrillation efficacy using implantable cardioverter–defibrillator with single- or dual-coil defibrillation leads and active can. Kardiol Pol 63:234–241PubMed

23.

Gold M, Val-Mejias J, Lennan RB, Tummala R, Goyal S, Kluger J et al (2008) Optimization of superior vena cava coil position and usage for transvenous defibrillation. Heart Rhythm 5:394–399PubMedCrossRef

24.

Bardy GH, Dolack L, Kudenchuk PJ, Poole JE, Mehra R, Johnson G (1994) Prospective, randomized comparison in humans of a unipolar defibrillation system with that using an additional superior vena cava electrode. Circulation 89:1090–1093PubMed

25.

Manolis AS, Chiladakis J, Maounis TN, Vassilikos V, Cokkinos DV (2000) Two-coil versus single-coil transvenous cardioverter defibrillator systems: comparative data. Pacing Clin Electrophysiol 23:1999–2002PubMedCrossRef

26.

Schulte B, Sperzel J, Carlsson J, Schwarz T, Ehrlich W, Pitschner HF, Neuzner J (2001) Dual-coil versus single-coil active pectoral implantable defibrillator lead systems: defibrillation energy requirements and probability of defibrillation success at multiples of the defibrillation energy requirements. Europace 3:177–180PubMedCrossRef

27.

Rinaldi CA, Simon RDB, Geelen P, Reek P, Baszko A, Kuehl M, Gill JS (2003) A randomized prospective study of single-coil versus dual-coil defibrillation in patients with ventricular arrhythmias undergoing implantable cardioverter defibrillator therapy. Pacing Clin Electrophysiol 26:1684–1690PubMedCrossRef

28.

Rüb N, Schweitzer O, Mewis C, Kettering K, Kuehlkamp V (2004) Addition of a defibrillation electrode in the low right atrium to a right ventricular lead does not reduce ventricular defibrillation thresholds. Pacing Clin Electrophysiol 27:346–351PubMedCrossRef

29.

Carlsson J, Schulte B, Erdogan A, Sperzel J, Güttler N, Schwarz T, Pitschner HF, Neuzner J (2003) Prospective randomized comparison of two defibrillation safety margins in unipolar, active pectoral defibrillation therapy. Pacing Clin Electrophysiol 26:613–618PubMedCrossRef

30.

Gold MR, Higgins S, Klein R, Gilliam R, Kopelman H, Hessen S, Payne J, Strickberger SA, Breiter D, Hahn S (2002) Efficacy and temporal stability of reduced safety margins for ventricular defibrillation. Primary results from the Low Energy Safety Study (LESS). Circulation 105:2043–2048PubMedCrossRef

31.

Val-Mejias JE, Oza A (2010) Does defibrillation threshold increase as left ventricular ejection fraction decreases? Europace 12:385–388PubMedCrossRef

32.

Morgan JM, Marinskis G (2011) Defibrillation testing at the time of implantable cardioverter defibrillator implantation: results of the European Heart Rhythm Association survey. Europace 13:581–582PubMedCrossRef

33.

Brigniole M, Raciti G, Bongiorni MG, Da Martine G, Favale S, Gasparini M, Luise R, Ochetta E, Prolemer A (2007) Defibrillation testing at the time of implantation of cardioverter defibrillator in the clinical practice: a nation-wide survey. Europace 9:540–543CrossRef

34.

Healey JS, Dorian P, Mitchell LB, Talajic M, Philioppon F, Simpson C, Yee R, Morillo CA, Lamy A, Basta M, Birnie DH, Wang X, Nair GM, Crystal E, Kerr CR, Connolly SJ (1010) Canadian Registry of ICD Implant Testing procedures (CREDIT): current practice, risks, and costs of intraoperative defibrillation testing. J Cardiovasc Electrophysiol 2:177–182

35.

Swerdlow CD, Russo AM, Degroot PJ (2007) The dilemma of ICD implant testing. Pace Clin Electrophysiol 30:675–700CrossRef

36.

Shockless Implant Evaluation “SIPMLE” Study; Clinical Trials.gov Identifier: NCT00800384

37.

Russo AM, Sauer W, Gerstenfeld EP, Hsia HH, Lin D, Cooper JM, Dixit S, Verdino RJ, Nayak HM, Callans DJ, Patel V, Marchlinski FE (2005) Defibrillation threshold testing: is it really necessary at the time of implantable cardioverter–defibrillator insertion? Heart Rhythm 5:456–461CrossRef

38.

Varma N, Efimov I (2008) Right pectoral implantable cardioverter defibrillators: role of the proximal (SVC) coil. Pacing Clin Electrophysiol 31:1025–1035PubMedCrossRef

39.

Epstein AE, Kay N, Plumb VJ, Voshage-Stahl L, Hull ML, for the Endotak investigators (1995) Elevated defibrillation thresholds when right sided venous access is used for nonthoracotomy implantable defibrillator lead implantation. J Cardiovasc Electrophysiol 6:979–986PubMedCrossRef

40.

Friedman PA, Rasmussen MJ, Grice S, Trusty J, Glikson M, Stanton MS (1999) Defibrillation thresholds are increased by right-sided implantation of totally transvenous implantable cardioverter defibrillators. Pacing Clin Electrophysiol 22:1186–1192PubMedCrossRef

41.

Gold MR, Shih HT, Herre J, Breiter D, Zhang Y, Schwarz M, for the Low Energy Safety Study Investigators (2007) Comparison of defibrillation efficacy and survival associated with right versus left pectoral placement for implantable defibrillators. Am J Cardiol 100:243–246PubMedCrossRef

42.

Flaker GC, Tummala R, Wilson J (1998) Comparison of right- and left-sided pectoral implantation parameters with the Jewel Active Can cardiodefibrillator. The World Wide Jewel Investigators. Pacing Clin Electrophysiol 21:447–451PubMedCrossRef

43.

Natale A, Sra J, Geiger MJ, Newby K, Akhtar M, Pacifico A (1997) Right side implant of the unipolar single lead defibrillation system. Pacing Clin Electrophysiol 20:1910–1912PubMedCrossRef

44.

Keane D, Aweh N, Hynes B, Sheahan RG, Cripps T, Bashir Y et al (2007) Achieving sufficient safety margins with fixed duration waveforms and the use of multiple time constants. Pacing Clin Electrophysiol 30:596–602PubMedCrossRef

45.

Swerdlow CD, Fan W, Brewer JE (1996) Charge-burping theory correctly predicts optimal ratios of phase duration for biphasic defibrillation waveforms. Circulation 94:2278–2284PubMed

46.

Irnich W (2010) From defibrillation theory to clinical implications. Pacing Clin Electrophysiol 33:814–825PubMedCrossRef

47.

Kroll MW, Schwab JO (2010) Acieving low defibrillation thresholds at implant: pharmacological influences, RV-coil polarity and position, SVC coil usage and positioning, pulse width settings, and the azygous vein. Fundam Clin Pharmacol 24:561–573PubMedCrossRef

48.

Stajduhar KC, Ott GY, Kron J, McAnulty JH, Oliver RP, Reynolds BT, Adler SW, Halperin BD (1996) Optimal electrode position for transvenous defibrillation: a prospective randomized study. J Am Coll Cardiol 27:90–94PubMedCrossRef

49.

Winter J, Heil JE, Schumann C, Lin Y, Schannwell CM, Michel U, Schipke JD, Schulte HD, Gams E (1998) Effect of implantable cardioverter/defibrillator lead placement in the right ventricle on defibrillation energy requirements. A combined experimental and clinical study. Eur J Cardiothorac Surg 14:419–425PubMedCrossRef

50.

Rashaba EJ, Bonner M, Wilson J, Shorofski SR, Peters RW, Gold MR (2003) Distal right ventricular coil position reduces defibrillation thresholds. J Cardiovasc Electrophysiol 14:1036–1040CrossRef

51.

Rashaba EJ, Shorofsky SR, Peters RW, Gold MR (2004) Optimization of atrial defibrillation with dual-coil, active pectoral lead system. J Cardiovasc Electrophysiol 15:790–794CrossRef

52.

Cooklin M, Olsovsky MR, Brockmann RG, Shorofsky SR, Gold MR (1999) Atrial defibrillation with a transvenous lead: a randomized comparison of active can shocking pathways. J Am Coll Cardiol 34:358–362PubMedCrossRef

53.

Rashaba EJ, Shorofski SR, Brown T, Peters RW, Gold MR (2005) Clinical predictors of atrial defrillation thresholds with a dual-coil, active pectoral lead system. Heart Rhythm 2:49–54CrossRef

54.

Rozmus G, Daubert JP, Huang DT, Rosero S, Hall B, Francis C (2005) Venous thrombosis and stenosis after implantation of pacemakers and defibrillators. J Interv Card Electrophysiol 13:9–19PubMedCrossRef

55.

Lickfett L, Bitzen A, Arepally A, Nasir K, Wolpert C, Jeong KM, Krause W, Schimpf R, Lewalter T, Calcins H, Jung W, Lüderitz B (2004) Incidence of venous obstruction following insertion of an implantable cardioverter defibrillator. A study of systematic contrast venography on patients presenting for their first elective ICD generator replacement. Europace 6:25–31PubMedCrossRef

56.

Parkash R, Crystal E, Bashir J, Simpson C, Birnie D, Sterns L, Exner D (2010) Complications associated with revision of Sprint Fidelis leads: report from the Canadian Heart Rhythm Society Device Advisory Committee. Circulation 121:2384–2387PubMedCrossRef

57.

Wilkoff BL, Love CJ, Byrd CL, Bongiorni MG, Camillo RG, Crossley GH 3rd et al (2009) Transvenous lead extraction: heart rhythm society expert consensus on facilities, training, indications, and patient management: this document was endorsed by the American Heart Association (AHA). Heart Rhythm 6:1085–1094PubMedCrossRef

58.

Kennergren C, Bjurman C, Wiklund R, Gäbel J (2009) A single-centre experience of over one thousand lead extractions. Europace 11:612–617PubMedCrossRef

59.

Bracke FALE, Meijer A, van Gelder LM (2002) Malfunction of endocardial defibrillator leads and lead extraction: where do they meet? Europace 4:19–24PubMedCrossRef

60.

Malecka B, Kutarski A, Grabowski M (2010) Is the transvenous extraction of cardioverter–defibrillator leads more hazardous than of pacemaker leads. Kardiol Pol 68:884–890PubMed

61.

Cooper JM, Stephenson EA, Berul CI, Walsh EP, Epstein LM (2003) Implantable cardioverter defibrillator lead complications and laser extraction in children and young adults with congenital heart disease: implications for implantation and management. J Cardiovasc Electrophysiol 14:344–349PubMedCrossRef

62.

Di Cori A, Bongiorni MG, Zucchelli G, Segreti L, Viani S, Paperini L, Soldati E (2010) Transvenous extraction performance of expanded polytetrafluoroethylene covered ICD leads in comparison to traditional ICD leads in humans. Pacing Clin Electrophysiol 33:1376–1381PubMedCrossRef

63.

Smith MC, Love CJ (2008) Extraction of transvenous pacing and ICD leads. Pacing Clin Electrophysiol 31:736–752PubMedCrossRef

64.

Hauser RG, Katsiyiannis WT, Gornick CC, Almquist AK, Kallinen LM (2010) Deaths and cardiovascular injuries due to device-assisted implantable cardioverter–defibrillator and pacemaker lead extraction. Europace 12:395–401PubMedCrossRef

65.

Farooqi FM, Talsania S, Hamid S, Rinaldi CA (2010) Extraction of cardiac rhythm devices: indications, techniques and outcomes for the removal of pacemaker and defibrillator leads. Int J Clin Pract 64:1140–1147PubMedCrossRef

66.

Bracke F (2008) Complications and lead extraction in cardiac pacing and defibrillation. Neth Heart J 16(Suppl 1):S28–S31PubMed

67.

Kennergren C, Bucknall CA, Butter C, Charles R, Fuhrer J, Grosfeld M et al (2007) Laser-assisted lead extraction: the European experience. Europace 9:651–656PubMedCrossRef

Title: Dual- versus single-coil implantable defibrillator leads: review of the literature
Authors: Jörg Neuzner
Jörg Carlsson
Publication date: 01-04-2012
Publisher: Springer-Verlag
Published in: Clinical Research in Cardiology / Issue 4/2012
Print ISSN: 1861-0684
Electronic ISSN: 1861-0692
DOI: https://doi.org/10.1007/s00392-011-0407-z

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Dual- versus single-coil implantable defibrillator leads: review of the literature

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2012

Concurrent drug eluting/bare metal stent implantation during percutaneous coronary intervention in target vessel: outcomes and 1-year follow-up

Coronary artery fistula with myocardial infarction due to steal syndrome

Sustained risk of recurrent thromboembolic events in patients with patent foramen ovale and paradoxical embolism: long-term follow-up over more than 15 years

Rapid assessment of longitudinal systolic left ventricular function using speckle tracking of the mitral annulus

Severe left main coronary stenosis in a young female patient, 6 years after mediastinal radiation therapy for non-Hodgkin lymphoma: assessment by coronary angiography and intravascular ultrasound

Polymorphisms of miRNAs genes are associated with the risk and prognosis of coronary artery disease

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page